Results per Page:
(TGF)Bait and Switch: Rewiring suppression into T cell power
From the Greenberg Lab, Translational Science and Therapeutics Division
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Multiple myeloma is treatable, not curable. Is that set to change?
Some experts believe a ‘functional cure’ is already within reach
AACR 2024: Liquid biopsies, better treatments and baseball
Fred Hutch scientist throws out first pitch, welcomes new AACR president at San Diego cancer conference
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
Dr. Philip Greenberg elected to National Academy of Sciences
Fred Hutch expert in immunology has led development of T-cell therapies for cancer
Overcoming exhaustion: Engineered T-cells and pancreas cancer
From the Greenberg Lab, Clinical Research Division, Fred Hutch and the Stromnes Lab, University of Minnesota
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
Dr. Phil Greenberg becomes president-elect of American Association for Cancer Research
Immunologist looks ahead to international leadership role
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Fred Hutch mourns sudden loss of Dr. Martin ‘Mac’ Cheever
A long career devoted to bringing immunotherapies from bench to bedside
Rewiring T cell death signaling enhances T cell function and persistence
From the Greenberg lab, Clinical Research Division
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
WT1 T-cell receptor transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division